Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis
Objective - Due to increasing waiting times for deceased donor kidneys, living donor kidney transplantation is increasingly performed in the presence of donor-specific antibodies (DSA). - Methods - Twenty-three patients with Luminex-detected DSA were successfully desensitized by anti-CD20 therapy an...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
26 January 2013
|
| In: |
Atherosclerosis. Supplements
Year: 2013, Volume: 14, Issue: 1, Pages: 199-202 |
| ISSN: | 1878-5050 |
| DOI: | 10.1016/j.atherosclerosissup.2012.10.030 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.atherosclerosissup.2012.10.030 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1567568812000414 
|
| Author Notes: | Katrin Klein, Caner Süsal, Sebastian M. Schäfer, Luis Eduardo Becker, Jörg Beimler, Vedat Schwenger, Martin Zeier, Peter Schemmer, Stephan Macher-Goeppinger, Sabine Scherer, Gerhard Opelz, Christian Morath |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1751707121 | ||
| 003 | DE-627 | ||
| 005 | 20240412193316.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210318s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.atherosclerosissup.2012.10.030 |2 doi | |
| 035 | |a (DE-627)1751707121 | ||
| 035 | |a (DE-599)KXP1751707121 | ||
| 035 | |a (OCoLC)1341399141 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Klein, Katrin |e VerfasserIn |0 (DE-588)1026480248 |0 (DE-627)726772305 |0 (DE-576)371826268 |4 aut | |
| 245 | 1 | 0 | |a Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis |c Katrin Klein, Caner Süsal, Sebastian M. Schäfer, Luis Eduardo Becker, Jörg Beimler, Vedat Schwenger, Martin Zeier, Peter Schemmer, Stephan Macher-Goeppinger, Sabine Scherer, Gerhard Opelz, Christian Morath |
| 264 | 1 | |c 26 January 2013 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 08.06.2022 | ||
| 520 | |a Objective - Due to increasing waiting times for deceased donor kidneys, living donor kidney transplantation is increasingly performed in the presence of donor-specific antibodies (DSA). - Methods - Twenty-three patients with Luminex-detected DSA were successfully desensitized by anti-CD20 therapy and immunoadsorption (N = 19) or plasmapheresis (N = 4) and received a kidney transplant from a living donor. Twelve of the 23 patients (52%) had a positive CDC and/or ELISA crossmatch result before desensitization. Six patients were negative in CDC as well as ELISA screening but positive in Luminex for DSA. - Results - The 23 patients received a median of 8 apheresis treatments before and 5 treatments after transplantation. Induction therapy was performed with either thymoglobulin (N = 11) or basiliximab (N = 12). The 2-year graft survival rate was 100%. At last follow up, a median of 12 months after transplantation, median serum creatinine was 1.42 mg/dL, median MDRD-GFR 59.5 mL/min/1.73 m2, and median urinary protein-to-creatinine ratio 0.12. Ten out of fourteen patients (71%) who had completed the first year after transplantation by the time of analysis had no DSA by day 360. Acute T-cell mediated rejection was diagnosed in one patient (4%), and antibody-mediated changes were found in 5 patients (22%). Four out of these 5 patients showed evidence of persistent (N = 2) or reemerging plus/minus de novo DSA (N = 2) on day 360, and the 2 patients with persistent DSA lost their allograft subsequently on days 750 and 810, respectively. Infectious complications were infrequent. - Conclusions - Our previously described treatment algorithm for desensitization of living donor kidney transplant recipients with DSA results in good graft outcomes with a low rate of side effects. | ||
| 650 | 4 | |a Desensitization | |
| 650 | 4 | |a Donor-specific antibodies | |
| 650 | 4 | |a Immunoadsorption | |
| 650 | 4 | |a Kidney transplantation | |
| 650 | 4 | |a Living donation | |
| 650 | 4 | |a Rituximab | |
| 700 | 1 | |a Süsal, Caner |e VerfasserIn |0 (DE-588)102648037X |0 (DE-627)726772763 |0 (DE-576)37182673X |4 aut | |
| 700 | 1 | |a Schäfer, Sebastian Markus |d 1985- |e VerfasserIn |0 (DE-588)1037798791 |0 (DE-627)756265444 |0 (DE-576)391831593 |4 aut | |
| 700 | 1 | |a Becker, Luis Eduardo |e VerfasserIn |0 (DE-588)1022494244 |0 (DE-627)716992442 |0 (DE-576)365485268 |4 aut | |
| 700 | 1 | |a Beimler, Jörg |d 1968- |e VerfasserIn |0 (DE-588)115360417 |0 (DE-627)691258740 |0 (DE-576)289834899 |4 aut | |
| 700 | 1 | |a Schwenger, Vedat |e VerfasserIn |0 (DE-588)1022867652 |0 (DE-627)717320197 |0 (DE-576)176592237 |4 aut | |
| 700 | 1 | |a Zeier, Martin |e VerfasserIn |0 (DE-588)1026480302 |0 (DE-627)726772356 |0 (DE-576)371826438 |4 aut | |
| 700 | 1 | |a Schemmer, Peter |d 1967- |e VerfasserIn |0 (DE-588)1022604244 |0 (DE-627)717006794 |0 (DE-576)365668230 |4 aut | |
| 700 | 1 | |a Macher-Göppinger, Stephan |e VerfasserIn |0 (DE-588)1022394061 |0 (DE-627)716963299 |0 (DE-576)365275034 |4 aut | |
| 700 | 1 | |a Scherer, Sabine |d 1961- |e VerfasserIn |0 (DE-588)123734568 |0 (DE-627)70641103X |0 (DE-576)293851417 |4 aut | |
| 700 | 1 | |a Opelz, Gerhard |d 1944- |e VerfasserIn |0 (DE-588)1026480345 |0 (DE-627)726772453 |0 (DE-576)371826527 |4 aut | |
| 700 | 1 | |a Morath, Christian |d 1973- |e VerfasserIn |0 (DE-588)124036155 |0 (DE-627)085595837 |0 (DE-576)293989923 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Atherosclerosis. Supplements |d Amsterdam [u.a.] : Elsevier Science, 2000 |g 14(2013), 1, Seite 199-202 |h Online-Ressource |w (DE-627)360058922 |w (DE-600)2098677-4 |w (DE-576)103116958 |x 1878-5050 |7 nnas |a Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis |
| 773 | 1 | 8 | |g volume:14 |g year:2013 |g number:1 |g pages:199-202 |g extent:4 |a Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.atherosclerosissup.2012.10.030 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S1567568812000414 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210318 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 124036155 |a Morath, Christian |m 124036155:Morath, Christian |d 50000 |e 50000PM124036155 |k 0/50000/ |p 12 |y j | ||
| 998 | |g 1026480345 |a Opelz, Gerhard |m 1026480345:Opelz, Gerhard |p 11 | ||
| 998 | |g 123734568 |a Scherer, Sabine |m 123734568:Scherer, Sabine |d 910000 |d 911600 |e 910000PS123734568 |e 911600PS123734568 |k 0/910000/ |k 1/910000/911600/ |p 10 | ||
| 998 | |g 1022394061 |a Macher-Göppinger, Stephan |m 1022394061:Macher-Göppinger, Stephan |d 910000 |d 912000 |e 910000PM1022394061 |e 912000PM1022394061 |k 0/910000/ |k 1/910000/912000/ |p 9 | ||
| 998 | |g 1022604244 |a Schemmer, Peter |m 1022604244:Schemmer, Peter |d 910000 |d 910200 |d 50000 |e 910000PS1022604244 |e 910200PS1022604244 |e 50000PS1022604244 |k 0/910000/ |k 1/910000/910200/ |k 0/50000/ |p 8 | ||
| 998 | |g 1026480302 |a Zeier, Martin |m 1026480302:Zeier, Martin |d 910000 |d 910100 |d 50000 |e 910000PZ1026480302 |e 910100PZ1026480302 |e 50000PZ1026480302 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 7 | ||
| 998 | |g 1022867652 |a Schwenger, Vedat |m 1022867652:Schwenger, Vedat |d 50000 |e 50000PS1022867652 |k 0/50000/ |p 6 | ||
| 998 | |g 115360417 |a Beimler, Jörg |m 115360417:Beimler, Jörg |d 50000 |e 50000PB115360417 |k 0/50000/ |p 5 | ||
| 998 | |g 1022494244 |a Becker, Luis Eduardo |m 1022494244:Becker, Luis Eduardo |d 50000 |e 50000PB1022494244 |k 0/50000/ |p 4 | ||
| 998 | |g 1037798791 |a Schäfer, Sebastian Markus |m 1037798791:Schäfer, Sebastian Markus |d 50000 |e 50000PS1037798791 |k 0/50000/ |p 3 | ||
| 998 | |g 102648037X |a Süsal, Caner |m 102648037X:Süsal, Caner |d 910000 |d 911600 |d 50000 |e 910000PS102648037X |e 911600PS102648037X |e 50000PS102648037X |k 0/910000/ |k 1/910000/911600/ |k 0/50000/ |p 2 | ||
| 998 | |g 1026480248 |a Klein, Katrin |m 1026480248:Klein, Katrin |d 50000 |e 50000PK1026480248 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1751707121 |e 3890643809 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"recId":"1751707121","type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 08.06.2022"],"title":[{"title_sort":"Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis","title":"Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis"}],"person":[{"roleDisplay":"VerfasserIn","display":"Klein, Katrin","role":"aut","family":"Klein","given":"Katrin"},{"role":"aut","display":"Süsal, Caner","roleDisplay":"VerfasserIn","given":"Caner","family":"Süsal"},{"display":"Schäfer, Sebastian Markus","roleDisplay":"VerfasserIn","role":"aut","family":"Schäfer","given":"Sebastian Markus"},{"display":"Becker, Luis Eduardo","roleDisplay":"VerfasserIn","role":"aut","family":"Becker","given":"Luis Eduardo"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Beimler, Jörg","given":"Jörg","family":"Beimler"},{"display":"Schwenger, Vedat","roleDisplay":"VerfasserIn","role":"aut","family":"Schwenger","given":"Vedat"},{"roleDisplay":"VerfasserIn","display":"Zeier, Martin","role":"aut","family":"Zeier","given":"Martin"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Schemmer, Peter","given":"Peter","family":"Schemmer"},{"display":"Macher-Göppinger, Stephan","roleDisplay":"VerfasserIn","role":"aut","family":"Macher-Göppinger","given":"Stephan"},{"given":"Sabine","family":"Scherer","role":"aut","roleDisplay":"VerfasserIn","display":"Scherer, Sabine"},{"given":"Gerhard","family":"Opelz","role":"aut","roleDisplay":"VerfasserIn","display":"Opelz, Gerhard"},{"roleDisplay":"VerfasserIn","display":"Morath, Christian","role":"aut","family":"Morath","given":"Christian"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedDisp":"2000-2020","dateIssuedKey":"2000","publisher":"Elsevier Science"}],"id":{"issn":["1878-5050"],"eki":["360058922"],"zdb":["2098677-4"]},"disp":"Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresisAtherosclerosis. Supplements","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Fortsetzung der Druck-Ausgabe","Gesehen am 16.11.2020"],"recId":"360058922","language":["eng"],"pubHistory":["1.2000 - 42.2020"],"titleAlt":[{"title":"Atherosclerosis / Supplements"}],"part":{"text":"14(2013), 1, Seite 199-202","volume":"14","extent":"4","year":"2013","pages":"199-202","issue":"1"},"title":[{"partname":"Supplements","title":"Atherosclerosis","title_sort":"Atherosclerosis"}]}],"physDesc":[{"extent":"4 S."}],"id":{"doi":["10.1016/j.atherosclerosissup.2012.10.030"],"eki":["1751707121"]},"origin":[{"dateIssuedDisp":"26 January 2013","dateIssuedKey":"2013"}],"name":{"displayForm":["Katrin Klein, Caner Süsal, Sebastian M. Schäfer, Luis Eduardo Becker, Jörg Beimler, Vedat Schwenger, Martin Zeier, Peter Schemmer, Stephan Macher-Goeppinger, Sabine Scherer, Gerhard Opelz, Christian Morath"]}} | ||
| SRT | |a KLEINKATRILIVINGDONO2620 | ||